The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...

BOSTON — The Endocrine Society has issued a new scientific statement advising clinicians to avoid using custom-compounded hormones to treat menopausal symptoms, female sexual dysfunction, and thyroid ...

NATIONAL HARBOR, Maryland — Anywhere from 1 million to 2.5 million women in the United States — about 2% of the female population older than 40 years — are using "bioidentical" compounded menopausal ...

Hormone therapy is the gold standard for treating VMS, but requires careful patient selection and shared decision-making. Timing, dose, and formulation of hormone therapy are crucial for safety and ...

When going through perimenopause and menopause, you’ll likely experience hot flashes, mood swings and other symptoms. This is because your body is changing and your hormone levels are fluctuating. To ...

Women will spend approximately one-third of their lives after the menopause transition and approximately 6,000 women reach menopause every day in the United States. While menopause is a natural ...

The American Diabetes Association (ADA) urged healthcare providers against prescribing non-FDA approved compounded GLP-1 and dual GIP/GIP-1 receptor agonists for type 2 diabetes or obesity and instead ...

Former site of US Compounding is acquired by up-and-comer in custom compounded pharmaceuticals, FarmaKeio, as part of ongoing expansion to support availability and delivery of custom compounded ...

WASHINGTON — Government health officials have begun cracking down on Internet sales of custom-mixed hormones for menopausal women, a market born when doctors deemed prescription estrogen therapy too ...

Custom-Compounded Therapy Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done ...